Mangaluru, April 2, 2015: Biocon, Bengaluru based Asia’s leading biotech enterprise, would set up manufacturing unit in Mangalore. Biocon’s research services arm Syngene International would set up a new plant at Mangalore SEZ to manufacture pharma ingredients and agro chemicals.
This was informed to Bombay Stock Exchange by the Biocon Limited; Kiran Muzumdar-shaw led company.
Biocon subsidiary Syngene International is in the process of acquiring approximately 40 acres of land on leasehold basis in the multi product category. This land would be used for setting up commercial scale facilities to manufacture novel active pharmaceuticals ingredients, advance ingredients and agro chemical for Syngene’s client.
Mangalore SEZ, a Special Purpose Vehicle, was incorporated on 24th February, 2006 with participation of ONGC, Infrastructure Leasing & Finance Corporation (IL&FS), Karnataka Chamber of Commerce and Industries (KCCI) and Karnataka Industrial Area Development Board (KIADB).
MSEZ is envisaged to be developed in two phases. MSEZ Phase I, notified as a sector specific Petrochemical SEZ, is being developed over an area of 1638 acres. Major Companies who are setting up their units in MSEZ Phase I are ONGC Mangalore Petrochemicals Ltd(OMPL), ISPRL, JBF Petrochemicals Ltd and Cardolite Specialties Chemicals Ltd.